These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 8131795)

  • 1. Fibrinogen as a cardiovascular risk factor--interrelationship with infections and inflammation.
    Ernst E
    Eur Heart J; 1993 Dec; 14 Suppl K():82-7. PubMed ID: 8131795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fibrinogen as a cardiovascular risk factor].
    Giannasi G; Ferrari S; Galetta F
    Minerva Cardioangiol; 1995 May; 43(5):169-75. PubMed ID: 7478039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fibrinogen. Cardiovascular risk factor or marker?].
    Canseco-Avila LM; Jerjes-Sánchez C; Ortiz-López R; Rojas-Martínez A; Guzmán-Ramírez D
    Arch Cardiol Mex; 2006; 76 Suppl 4():S158-72. PubMed ID: 17469344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fibrinogen as a cardiovascular risk factor--marker or causal factor?].
    Halvorsen S
    Tidsskr Nor Laegeforen; 1999 Aug; 119(19):2829-32. PubMed ID: 10494205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Fibrinogen: factor and marker of cardiovascular risk].
    Drouet L; Bal Dit Sollier C
    J Mal Vasc; 2002 Jun; 27(3):143-56. PubMed ID: 12232531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen and viscosity: risk factors for cardiovascular events.
    Resch KL; Ernst E
    Compr Ther; 1994; 20(3):170-3. PubMed ID: 8187458
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrinogen and cardiovascular risk.
    Heinrich J; Assmann G
    J Cardiovasc Risk; 1995 Jun; 2(3):197-205. PubMed ID: 7584794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Older age and markers of inflammation are strong predictors of clinical events in women with asymptomatic carotid lesions.
    Corrado E; Rizzo M; Muratori I; Coppola G; Novo S
    Menopause; 2008; 15(2):240-7. PubMed ID: 17917609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent progress in the "fibrinogen hypothesis"].
    Lefebvre P; Ledent T; Ducobu J
    Rev Med Brux; 2003 Apr; 24(2):82-7. PubMed ID: 12806874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of chronic Chlamydia infection with non-specific inflammation on cardiovascular complications in acute myocardial infarct].
    Jaber AJ; Murín J; Hricák V; Tomasovic B; Kinová S; Kozlíková K; Ghanem W; Radman A
    Vnitr Lek; 2003 Feb; 49(2):109-14. PubMed ID: 12728577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L; Uzick M
    Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinogen and cardiovascular disorders.
    Lip GY
    QJM; 1995 Mar; 88(3):155-65. PubMed ID: 7767665
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibrinogen: a new major risk factor for cardiovascular disease. A review of the literature.
    de la Serna G
    J Fam Pract; 1994 Nov; 39(5):468-77. PubMed ID: 7964545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Inflammation and C-reactive protein in cardiovascular disease].
    Munk PS; Larsen AI
    Tidsskr Nor Laegeforen; 2009 Jun; 129(12):1221-4. PubMed ID: 19521445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study.
    Tzoulaki I; Murray GD; Price JF; Smith FB; Lee AJ; Rumley A; Lowe GD; Fowkes FG
    Am J Epidemiol; 2006 Feb; 163(4):334-41. PubMed ID: 16357107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community.
    McDonald S; Maguire G; Duarte N; Wang XL; Hoy W
    Clin Sci (Lond); 2004 Feb; 106(2):121-8. PubMed ID: 12956621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum albumin predicts cardiac adverse events in patients with advanced atherosclerosis - interrelation with traditional cardiovascular risk factors.
    Schillinger M; Exner M; Mlekusch W; Amighi J; Sabeti S; Schlager O; Wagner O; Minar E
    Thromb Haemost; 2004 Mar; 91(3):610-8. PubMed ID: 14983239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation of educational level to inflammation-sensitive biomarker level.
    Steinvil A; Shirom A; Melamed S; Toker S; Justo D; Saar N; Shapira I; Berliner S; Rogowski O
    Am J Cardiol; 2008 Oct; 102(8):1034-9. PubMed ID: 18929705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study.
    Lee AJ; Fowkes FG; Lowe GD; Connor JM; Rumley A
    Thromb Haemost; 1999 Apr; 81(4):553-60. PubMed ID: 10235438
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Fibrinogen: cardiovascular risk factor].
    Espinosa RA;
    Invest Clin; 2002 Dec; 43(4):291-301. PubMed ID: 12521001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.